Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01804673
Recruitment Status : Terminated (The study was prematurely discontinued since study medication was no longer available.)
First Posted : March 5, 2013
Results First Posted : August 5, 2013
Last Update Posted : August 5, 2013
Sponsor:
Information provided by (Responsible Party):
Janssen-Cilag G.m.b.H

Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of the fentanyl iontophoretic transdermal (through the skin) system (fentanyl-ITS) in daily clinical practice for management of acute (a quick and severe form of illness in its early stage) moderate to severe post-operative pain (pain after surgery) including the comprehensibility and usefulness of the accompanying information material.

Condition or disease Intervention/treatment Phase
Postoperative Pain Drug: Fentanyl-ITS Phase 4

Detailed Description:
This is an open label (all people know the identity of the intervention), single arm, and multi-center (when more than one hospital or medical school team work on a medical research study) study to evaluate safety and efficacy of the fentanyl-ITS for management of acute moderate to severe pain in post-operative participants' who have undergone elective surgery (surgery which could be postponed or not done at all without danger to the participant). The study will consists of 2 phases: screening phase (which comprises of pre-operative and post-operative stages) and an open label treatment phase. The participants will be treated with 40 microgram (mcg) of fentanyl transdermally per on-demand dose; each delivered over 10 minutes for a maximum of 6 doses (240 mcg) per hour for 24 hours and a maximum of 80 doses (3.2 milligram [mg]). Each system will inactivate at 80 doses or 24 hour, whichever occurs first. A new system will be applied every 24 hours unless the participant has used 80 doses in less than 24 hours. Maximum treatment duration of 72 hours is allowed. Participants will be expected to require parenteral (administration by injection) opioids (morphine like medications) for at least 24 hours post-operatively. This study will evaluate participant's, nurse's and physician's assessment of fentanyl-ITS under routine conditions. Participants' safety will be monitored throughout the study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 174 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Global Assessment of Treatment With IONSYS and Its Handling by Patients, Doctors and Nursing Staff in the Management of Acute Moderate to Severe Post-Surgery Pain in Hospitalised Patients
Study Start Date : March 2008
Actual Primary Completion Date : September 2008
Actual Study Completion Date : September 2008

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Fentanyl-ITS Drug: Fentanyl-ITS
Fentanyl Iontophoretic Transdermal (through the skin) System (ITS) will release fentanyl at the rate of 40 microgram (mcg) (1 dose) to maximum of 240 mcg per hour (6 doses) but not more than 3.2 milligram (mg) (80 doses) per 24 hours. The duration of study treatment will be 72 hours.
Other Name: IONSYS, Fentanyl-ITS




Primary Outcome Measures :
  1. Percentage of Participants With Global Assessment of Pain at Hour 24 [ Time Frame: Hour 24 ]
    Participants were asked to rate their overall global assessment of pain therapy with study treatment on a 4-point verbal rating scale (poor, fair, good, excellent). Outcome of 'good' or 'excellent ' was recorded as Response while outcome of 'poor' or 'fair' was recorded as No response.


Secondary Outcome Measures :
  1. Number of Hours Per Day With Average Pain Intensity Less Than or Equal to 4 [ Time Frame: Baseline to Hour 24, Hour 24 to Hour 48 and Hour 48 to Hour 72 ]
    Number of hours per day with average pain intensity less than or equal to 4 was measured on a 11-point Numeric Rating Scale (NRS) (range 0 to 10, 0=no pain; 4=mild pain; 10=strongest pain imaginable). If the participant was sleeping at time of measurement, pain intensity was assumed to be less than or equal to 4.

  2. Change From Baseline in Pain Intensity Rating at Hour 24, 48 and 72 [ Time Frame: Baseline, Hour 24, 48 and 72 ]
    Nursing staff asked the participants to rate their current pain intensity on 11-point NRS (range 0 to 10, 0= no pain; 10= strongest pain imaginable).

  3. Time Spent Out of the Bed Per Day by the Participant [ Time Frame: Baseline to Hour 24, Hour 24 to Hour 48 and Hour 48 to Hour 72 ]
    Participants were asked to enter the time in hours spend out of bed during the last 24 hours in the participant diary.

  4. Time to Mobilization [ Time Frame: Baseline, Hours 24, 48 and 72 ]
    Participants were asked to describe their time schedule for particular steps of mobilization by answering specific questions in the participant diary.

  5. Percentage of Participants With Global Assessment of Pain at Hour 48 and 72 [ Time Frame: Hours 48 and 72 ]
    Participants were asked to give their overall global assessment of pain therapy with study treatment using a 4-point verbal rating scale (poor, fair, good, excellent). Outcome of 'good' or 'excellent ' was recorded as Response while outcome of 'poor' or 'fair' was recorded as No response.

  6. Percentage of Participants With Physician Global Assessment of Pain [ Time Frame: Hours 24, 48 and 72 ]
    Physicians were asked to give their overall global assessment of pain therapy with study treatment using a 4-point verbal rating scale (poor, fair, good, excellent). Outcome of 'good' or 'excellent ' was recorded as Response while outcome of 'poor' or 'fair' was recorded as No response.

  7. Percentage of Participants With Nursing Staff Global Assessment of Pain [ Time Frame: Hours 24, 48 and 72 ]
    Nursing Staff were asked to give their overall global assessment of pain therapy with study treatment using a 4-point verbal rating scale (poor, fair, good, excellent). Outcome of 'good' or 'excellent ' was recorded as Response while outcome of 'poor' or 'fair' was recorded as No response.

  8. Physician's Evaluation of Participant's Ability to Undergo Physiotherapy or Mobilization [ Time Frame: Hours 24, 48 and 72 ]
    Physicians were asked to rate the participant's ability to undergo physiotherapy or mobilization by responding to following questions of a questionnaire: Part 1 A- Does the surgical procedure performed allow the mobilization of the participant, C- Was the mobilization of the participant limited due to pain, D- Is the participant in a condition to undergo physiotherapy; Part 2 A- Was it possible to mobilize the participant sooner than with other pain therapies, B- Does the participant move more, C- Is the participant less afraid of moving. For Part 1-Question C, 'Partial' indicates that mobilization of participant was moderately limited due to pain.

  9. Comprehensibility of the Information Material (IM): Physician Questionnaire Responses [ Time Frame: Hour 72 ]
    Physicians were asked to evaluate the IM for fentanyl-ITS (IONSYS) by responding to following questions of a questionnaire: Part2 D- Would you use IONSYS again, E- Would you prefer IONSYS to intravenous patient controlled analgesia (IV PCA); Part3 A- Was IM easy to understand, B- Did IM help you to use system properly.

  10. Comprehensibility of the Information Material (IM): Nursing Staff Questionnaire Responses [ Time Frame: Hour 72 ]
    Nursing staff were asked to evaluate the IM for IONSYS by responding to following questions of a questionnaire: IM A- Was IM easy to understand, B- Did IM help you to use system properly; IONSYS PCA A- Is system easy to handle, B- Did participant need help in using system, C- Do you feel confident using IONSYS; IV PCA- Are you experienced in using IV PCA; IONSYS PCA D- Could participant get mobilized sooner, E- Does participant move more, F- Is participant less afraid of moving, G- Were hospital logistics for IONSYS easier to handle.

  11. Comprehensibility of the Information Material (IM): Participant Questionnaire Responses [ Time Frame: Hour 72 ]
    Participants were asked to evaluate the IM for IONSYS by responding to following questions of a questionnaire: A- Is IONSYS easy to use, B- Were you able to operate the system by yourself after receiving instructions, C- Have you found button yourself, D- Was pressing button easy, E- Have you heard system's beeps, F- Was IONSYS IM easy to understand, G- Did IM help you to use system, H- Did you have problems falling asleep, I- Could you move easily in bed, J- Did system bother you during physiotherapy, K- Do you perceive use of such system as modern treatment standard.

  12. Post-Operative Phase (PPP33) Quality of Life Questionnaire Score [ Time Frame: Hour 72 ]
    The PPP33 questionnaire has an overall score and 8 subscales that represent different aspects of the post-operative quality of life: information, autonomy, communication, physical complaints, pain, rest, fear and accommodation. Answers to individual question are scored with values 1 to 4. Summary scores are calculated by adding values for each question. Subscores ranges depend on the number of questions evaluated (2 to 7 questions). The overall score ranges from 1 to 100. Higher scores indicate less pain.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Participants with American Society of Anesthesiology (specialty concerned with the study of anesthetics [drug that is used to produce loss of pain sensation] and anesthesia [loss of sensation or feeling]) pre-operative physical status 1, 2 or 3
  • Participants who are expected to remain hospitalized for at least 24 hours post-operatively (after the surgery)
  • Participants, after an elective major surgical procedure (surgery which could be postponed or not done at all without danger to the participant), who are expected to have moderate or severe pain requiring parenteral (administration by injection) opioids (morphine like medications) for at least 24 hours after surgery
  • Participants who are capable of understanding and cooperating with the requirements of the study and operating a transdermal (through the skin) Patients-Controlled Analgesia (PCA; methods of pain relief that may be used with or in place of analgesics [drug used to control pain])
  • Participants with a pain score less than or equal to 4 (moderate pain) out of 10 on a Numerical Rating Scale (NRS), whereas 0 corresponds to no pain and 10 to the strongest imaginable pain at movement of the operated limb or body region, after titration (slow increase in drug dosage, guided by participant's responses) to comfort according to current postoperative procedures

Exclusion Criteria:

  • Participants allergic or hypersensitive (very sensitive) to fentanyl or cetylpyridinium chloride or to skin adhesives
  • Participants who are known or suspected to be strong opioid dependent, or who have a very high a need for strong opioids before entering the study
  • Participants with a history of psychological opioid dependence before the start of the study
  • Participants who are known or suspected to have abused any drug substance or alcohol in the opinion of the investigator
  • Women who are pregnant, breast feeding, or planning to breast feed within 24 hrs of the last dose of study drug.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01804673


Locations
Layout table for location information
Germany
Augsburg, Germany
Berlin, Germany
Bremen, Germany
Detmold, Germany
Dresden, Germany
Erfurt, Germany
Erlangen, Germany
Frankfurt, Germany
Halle, Germany
Jena, Germany
Kiel, Germany
Köln, Germany
Leipzig, Germany
Lünen, Germany
Mainz, Germany
Mannheim, Germany
Marburg, Germany
Münster, Germany
Ravensburg, Germany
Regensburg, Germany
Schwerin, Germany
Solingen, Germany
Sponsors and Collaborators
Janssen-Cilag G.m.b.H
Investigators
Layout table for investigator information
Study Director: Janssen-Cilag G.m.b.H, Germany Clinical Trial Janssen-Cilag G.m.b.H
Layout table for additonal information
Responsible Party: Janssen-Cilag G.m.b.H
ClinicalTrials.gov Identifier: NCT01804673    
Other Study ID Numbers: CR005440
FEN-PAI-3002
2005-004087-24 ( EudraCT Number )
First Posted: March 5, 2013    Key Record Dates
Results First Posted: August 5, 2013
Last Update Posted: August 5, 2013
Last Verified: August 2013
Keywords provided by Janssen-Cilag G.m.b.H:
Postoperative Pain
Fentanyl Hydrochloride
IONSYS
Additional relevant MeSH terms:
Layout table for MeSH terms
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Neurologic Manifestations
Fentanyl
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Adjuvants, Anesthesia
Anesthetics, Intravenous
Anesthetics, General
Anesthetics